Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre

There is a paucity of data regarding mixed mold pulmonary infections (MMPIs) in patients with haematological malignancies with or without haematopoietic stem cell transplantation (HSCT). We retrospectively studied 27 such patients (2005-2015) and compared them to patients with invasive pulmonary aspergillosis (IPA) caused by Aspergillus fumigatus. Factors associated with the diagnosis of MMPIs were significant corticosteroid use [20 (74%) vs 6 (22%), P<0.001], sputum as the source specimen [13 (48%) vs 3 (11%), P=0.003], younger age (median age: 58 vs 66years, P=0.006), and male sex [22 (81%) vs 13 (48%), P=0.01]. Haematological cancers other than acute myeloid leukaemia (AML)/myelodysplastic syndromes (MDS) were less common in MMPIs than in IPA patients [AML/MDS: 6 (22%) vs 14 (52%), P=0.04]. Only significant corticosteroid use [95% CI (2.7-42.7), P<0.001], and sputum as the source specimen [95% (1.6-41.6), P=0.012] were statistically significant as independently associated with increased risk of MMPIs diagnosis in multivariate analysis. Total mortality rate at day 42 postdiagnosis was comparable in both groups.